Clinical trial
Incremental Value of Heart-type Fatty Acid-Binding Protein (H-FABP) in Evaluating Patients Presenting With Symptoms Possibly Matching Acute Coronary Syndrome in Primary Care
NCT01826994 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incremental Value of Heart-type Fatty Acid-Binding Protein (H-FABP) in Evaluating Patients Presenting With Symptoms Possibly Matching Acute Coronary Syndrome in Primary Care
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- December 31, 2016
- Enrollment
- 303 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, angina pectoris, stable, angina pectoris, unstable, thoracic diseases